National Institute on Aging; Notice of Closed Meetings, 16489-16490 [2010-7344]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 62 / Thursday, April 1, 2010 / Notices
such as patentable material and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Experimental Therapeutics Program (NExT)
SEP February 2010 Cycle 3.
Date: April 30, 2010.
Time: 8:30 a.m.–4:30 p.m.
Agenda: To evaluate the NCI Experimental
Therapeutics Program Portfolio.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Dr. Barbara Mroczkowski,
Executive Secretary, NCI Experimental
Therapeutics Program, National Cancer
Institute, NIH, 31 Center Drive, Room 3A44,
Bethesda, MD 20817, (301) 496–4291,
mroczkowskib@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSKH9S0YB1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Review of NIAAA Member
Application.
Date: April 7, 2010.
Jkt 220001
[FR Doc. 2010–7345 Filed 3–31–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute on Aging; Notice of
Closed Meetings
[FR Doc. 2010–7346 Filed 3–31–10; 8:45 am]
16:51 Mar 31, 2010
Dated: March 26, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Institutes of Health
Dated: March 26, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
VerDate Nov<24>2008
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Mark P. Rubert, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1775, rubertm@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Effect of
Energy Flux on Risk Factors for Age-Related
Chronic Diseases. I
Date: May 3, 2010.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: Ramesh Vemuri, PhD,
Chief, Scientific Review Branch, National
Institute on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Suite 2C–
212, Bethesda, MD 20892, 301–402–7700,
rv23r@nih.gov.
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
16489
Name of Committee: National Institute on
Aging Special Emphasis Panel; Health Care
Spending.
Date: May 5, 2010.
Time: 1:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C218, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Alfonso R. Latoni, PhD,
Deputy Chief, Scientific Review Branch,
National Institute on Aging, 7201 Wisconsin
Avenue, Suite 2C218, Bethesda, MD 20892,
301–402–7702, Alfonso.Latoni@nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Diet
Restriction.
Date: May 6, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: Alicja L Markowska, PhD,
DSC, Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
7201 Wisconsin Avenue, Suite 2C212,
Bethesda, MD 20892, 301–496–9666,
markowsa@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Amyloid
Imaging In Aging and Dementia.
Date: May 17, 2010.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: Alexander Parsadanian,
PhD, Scientific Review Officer, National
Institute on Aging, Gateway Building 2C/212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–496–9666,
PARSADANIANA@NIA.NIH.GOV.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Basis of
Myocardial Injury in the Elderly.
Date: May 27, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: Elaine Lewis, PhD,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, Gateway
Building, Suite 2C212, MSC–9205, 7201
Wisconsin Avenue, Bethesda, MD 20892,
301–402–7707, elainelewis@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Nutrient
Signaling II.
Date: June 14, 2010.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
E:\FR\FM\01APN1.SGM
01APN1
16490
Federal Register / Vol. 75, No. 62 / Thursday, April 1, 2010 / Notices
Suite 2C212, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: Bita Nakhai, PhD,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, Gateway
Bldg., 2C212, 7201 Wisconsin Avenue,
Bethesda, MD 20814, 301–402–7701,
nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Adiposity,
Aging, and Stem Cells.
Date: June 23, 2010.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: Rebecca J. Ferrell, PhD,
Scientific Review Officer, National Institute
on Aging, Gateway Building Rm. 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892,
301–402–7703, ferrellrj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: March 29, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–7344 Filed 3–31–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: Development of PANVAC and
Tumor Associated Antigens as Cancer
Vaccines
mstockstill on DSKH9S0YB1PROD with NOTICES
AGENCY: National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
SUMMARY: This is notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
part 404.7(a)(1)(i), that the National
Institutes of Health, Department of
Health and Human Services, is
contemplating the grant of an exclusive
patent license to practice the inventions
embodied in the following U.S. Patents
and Patent Applications to Bavarian
Nordic Immunotherapeutics (‘‘BNIT’’)
located in Mountain View, CA, USA.
Intellectual Property:
1. U.S. Patent No. 6,756,038 issued
June 29, 2004 as well as issued and
pending foreign counterparts [HHS Ref.
No. E–099–1996/0–US–07];
2. U.S. Patent Application No. 10/
725,373 (recently allowed) filed
December 3, 2003 as well as
continuation and divisional
applications, and issued and pending
foreign counterparts [HHS Ref. No. E–
099–1996/0–US–08];
VerDate Nov<24>2008
16:51 Mar 31, 2010
Jkt 220001
3. U.S. Patent No. 6,001,349 issued 14
Dec. 1999 as well as issued and pending
foreign counterparts [HHS Ref. No. E–
200–1990/3–US–01];
4. U.S. Patent Application No. 10/
579,025 filed May 11, 2006 as well as
all continuation and divisional
applications, and issued and pending
foreign counterparts [E–087–2005/0–
US–03];
5. U.S. Patent Application No. 10/
579,007 filed May 11, 2006 as well as
all continuation and divisional
applications, and issued and pending
foreign counterparts [E–088–2005/0–
US–03];
6. U.S. Patent No. 7,118,738 issued
October 10, 2006 as well as all
continuations and divisional
applications, and issued and pending
foreign counterparts [HHS Ref. No. E–
154–1998/0–US–07];
7. U.S. Patent Application Nos. 08/
686,280 filed July 25, 1996 as well as all
issued and pending foreign counterparts
[HHS Ref. No. E–259–1994/3–US–01];
8. U.S. Patent No. 7,410,644 issued
August 12, 2008 as well as all
continuation and divisional
applications, and issued and pending
foreign counterparts [HHS Ref. No. E–
259–1994/3–US–08];
9. U.S. Patent Nos. 6,893,869,
6,548,068 and 6,045,802 issued May 17,
2005, April 15, 2003 and April 4, 2000
respectively, as well as issued and
pending foreign counterparts [HHS Ref.
Nos. E–260–1994/1–US–03, US–02, US–
01]; U.S. Patent No. 7,368,116 issued
May 6, 2008 and U.S. Patent
Application No. 12/112,819, as well as
all continuation and divisional
applications [HHS Ref. Nos. E–260–
1994/1–US–04 and US–05];
10. Europe Patent Application No.
00102998.2 filed October 2, 1995,
Europe Patent No. 0784483 issued
November 29, 2001, Europe Patent
Application No. 09013495.8 filed
October 26, 2009, as well as all
continuation, and divisional
applications [HHS Ref. Nos. E–260–
1994/2–EP–15, EP–16 and EP–27]; Japan
Patent Application No. 512100/96 filed
October 2, 1995; Japan Patent No.
4078319 issued February 8, 2008 [HHS
Ref. No. E–260–1994/2–JP–25]; and
Japan Patent No. 4160612 issued July
25, 2008, as well as all continuation and
divisional applications; [HHS Ref. No.
E–260–1994/2–JP–21, JP–25 and JP–26];
Australia Patent No. 688606 issued July
2, 1998 [E–260–1994/2–AU–11]; Canada
Patent No. 2201587 issued June 25, 2002
[E–260–1994/2–CA–12];
11. Canada Patent Application No.
2,412,050 filed June 15, 2001 [HHS Ref.
No. E–187–2000/0–CA–05]; Australia
Patent No. 2001268452 issued
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
November 30, 2006 [HHS Ref. No. E–
187–2000/0–AU–06]; Japan Patent
Application No. 2002–510097 filed June
15, 2001 [HHS Ref. No. E–187–2000/0–
JP–07]; Hong Kong Patent Application
No. 03105975.5 filed June 15, 2001
[HHS Ref. No. E–187–2000/0–HK–08];
as well as all continuation and
divisional applications;
12. U.S. Patent Application No. 12/
280,534 filed February 21, 2007, [HHS
Ref. No. E–104–2006/0–US–06];
Australia Patent Application No.
2007221255 filed February 21, 2007
[HHS Ref. No. E–104–2006/0–AU–03];
Europe Patent Application No.
07751371.1 filed February 21, 2007,
[HHS Ref. No. E–104–2006/0–US–06];
filed February 21, 2007, [HHS Ref. No.
E–104–2006/0–EP–05]; Canada Patent
Application No. 2642994 filed February
21, 2007 [HHS Ref. No. E–104–2006/0–
CA–04]; as well as all continuation and
divisional and applications;
13. U.S. Patent Application No. 12/
528,796 filed August 26, 2009 [HHS Ref.
No. E–074–2007/0–US–07]; Australia
Patent Application No. 2008221383
filed February 27, 2008 [HHS Ref. No.
E–074–2007/0–AU–03]; Europe Patent
Application No. 08743578.0 filed
February 27, 2008 [HHS Ref. No. E–074–
2007/0–EP–05]; Canada Patent
Application No. 2,678,404 filed
February 27, 2008 [HHS Ref. No. E–074–
2007/0–CA–04]; Japan Patent
Application No. not yet assigned filed
February 27, 2008 [HHS Ref. No. E–074–
2007/0–JP–06] as well as all
continuation, divisional and pending
foreign counterpart applications;
Group II—Nonexclusive Licensed
Patent Rights:
1. U.S. Patent No. 6,969,609 issued
November 29, 2005; U.S. Patent No.
7,211,432 issued May 1, 2007; U.S.
Patent Application No. 11/723,666 filed
March 21, 2007; as well as all
continuation and divisional
applications, and issued and pending
foreign counterparts [HHS Ref. No. E–
256–1998/0, 1];
2. U.S. Patent Application Nos. 60/
448,591 and 10/543,944 filed February
20, 2003 and February 20, 2004
respectively, as well as all continuation
and divisional applications, and issued
and pending foreign counterparts [HHS
Ref. No. E–028–2007/0];
3. U.S. Patent No. 6,699,475 issued
March 2, 2004, as well as all
continuation and divisional
applications, and issued and pending
foreign counterparts [HHS Ref. No. E–
134–2007/0];
4. U.S. Patent No. 5,093,258 issued
March 3, 1992, as well as all
continuation and divisional
applications, and issued and pending
E:\FR\FM\01APN1.SGM
01APN1
]]>Agencies
[Federal Register Volume 75, Number 62 (Thursday, April 1, 2010)]
[Notices]
[Pages 16489-16490]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-7344]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Effect of Energy Flux on Risk Factors for Age-Related Chronic
Diseases. I
Date: May 3, 2010.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, (Telephone
Conference Call)
Contact Person: Ramesh Vemuri, PhD, Chief, Scientific Review
Branch, National Institute on Aging, National Institutes of Health,
7201 Wisconsin Avenue, Suite 2C-212, Bethesda, MD 20892, 301-402-
7700, rv23r@nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Health Care Spending.
Date: May 5, 2010.
Time: 1:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C218, Bethesda, MD 20892. (Telephone
Conference Call)
Contact Person: Alfonso R. Latoni, PhD, Deputy Chief, Scientific
Review Branch, National Institute on Aging, 7201 Wisconsin Avenue,
Suite 2C218, Bethesda, MD 20892, 301-402-7702,
Alfonso.Latoni@nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Diet Restriction.
Date: May 6, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, (Telephone
Conference Call)
Contact Person: Alicja L Markowska, PhD, DSC, Scientific Review
Officer, Scientific Review Branch, National Institute on Aging, 7201
Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301-496-9666,
markowsa@nia.nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Amyloid Imaging In Aging and Dementia.
Date: May 17, 2010.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, (Telephone
Conference Call)
Contact Person: Alexander Parsadanian, PhD, Scientific Review
Officer, National Institute on Aging, Gateway Building 2C/212, 7201
Wisconsin Avenue, Bethesda, MD 20892, 301-496-9666,
PARSADANIANA@NIA.NIH.GOV.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Basis of Myocardial Injury in the Elderly.
Date: May 27, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, (Telephone
Conference Call)
Contact Person: Elaine Lewis, PhD, Scientific Review Officer,
Scientific Review Branch, National Institute on Aging, Gateway
Building, Suite 2C212, MSC-9205, 7201 Wisconsin Avenue, Bethesda, MD
20892, 301-402-7707, elainelewis@nia.nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Nutrient Signaling II.
Date: June 14, 2010.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue,
[[Page 16490]]
Suite 2C212, Bethesda, MD 20892, (Telephone Conference Call)
Contact Person: Bita Nakhai, PhD, Scientific Review Officer,
Scientific Review Branch, National Institute on Aging, Gateway
Bldg., 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20814, 301-402-
7701, nakhaib@nia.nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Adiposity, Aging, and Stem Cells.
Date: June 23, 2010.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, (Telephone
Conference Call)
Contact Person: Rebecca J. Ferrell, PhD, Scientific Review
Officer, National Institute on Aging, Gateway Building Rm. 2C212,
7201 Wisconsin Avenue, Bethesda, MD 20892, 301-402-7703,
ferrellrj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: March 29, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-7344 Filed 3-31-10; 8:45 am]
BILLING CODE 4140-01-P
